查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933861

医用二尖瓣环状成形术环市场（按器械类型、手术类型、材料类型、病患年龄层和最终用户管道划分）－全球预测，2026-2032年

Medical Mitral Annuloplasty Ring Market by Device Type, Procedure Type, Material Type, Patient Age Group, End User Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，医用二尖瓣环状成形术环市场价值为 3.2345 亿美元，预计到 2026 年将成长至 3.5232 亿美元，到 2032 年将达到 5.8732 亿美元，复合年增长率为 8.89%。

主要市场统计数据
基准年 2025 3.2345亿美元
预计年份：2026年 3.5232亿美元
预测年份：2032年 5.8732亿美元
复合年增长率 (%) 8.89%

简洁扼要、权威详尽地介绍了二尖瓣环状成形术环在现代心臟修復中不断演变的作用和战略决策。

二尖瓣环状成形术环在现代瓣膜修復中发挥核心作用，影响不同病患群体的手术选择、器械创新和临床疗效。近年来，瓣环设计、材料科学和植入技术的不断改进，为外科医生和心臟病专家拓展了治疗选择。随着临床适宜时修復手术逐渐取代置换手术，人们对瓣环形态、顺应性和组织相互作用的关注度日益提高，促使製造商和临床团队重新评估其器械选择框架。

持续的设计创新、材料进步、程序变更和监管要求如何重新定义二尖瓣环环状成形术环的开发和应用

二尖瓣瓣环成形术段正经历多项变革，这些变革正在重塑临床实践和产业发展方向。首先，器械设计的演变正超越刚性与柔性结构的二元选择，转向旨在平衡瓣环重塑和生理运动的混合解决方案。半刚性和鞍形刚性器材的创新，透过为不同病理情况提供客製化的动态特性，正在改变术中决策。

分析 2025 年美国关税变化如何促使设备製造商加强供应链韧性、转变采购方式并进行商业性。

2025年实施的关税政策变更给整个医疗设备供应链带来了复杂的挑战，并促使其进行策略性调整，这与二尖瓣环环状成形术环的供应和价格波动密切相关。具体而言，某些零件和原材料进口关税的提高增加了到岸成本，迫使製造商重新评估其筹资策略和库存管理政策。为因应这项变化，各公司加快了近岸外包的步伐，并使其供应商网路多元化，以分散风险，同时确保器械品质并符合监管要求。

详细的分析阐述了设备设计、手术流程、终端用户环境、材料以及患者年龄如何影响临床和商业策略。

细緻的市场细分框架揭示了不同器械类型、手术类型、终端用户管道、材料选择和患者群体特征所带来的独特临床和商业性影响。按器械类型分類的市场特征包括：柔性环（包括二尖瓣和单尖瓣设计）；刚性环（圆形和鞍形几何形状）；以及半刚性环（有全封闭式和开放式设计）。每种类型都针对不同的二尖瓣病变和手术方法，因此需要有针对性的证据资料和外科医生培训计划。

区域比较分析突显了美洲、欧洲、中东、非洲和亚太地区在临床应用、法规结构和支付方趋势方面的差异。

区域趋势持续影响美洲、欧洲、中东和非洲以及亚太地区的临床实践模式、监管要求和商业化策略。在美洲，高手术量、二尖瓣修復手术转换率高以及成熟的学术中心网络推动了创新瓣环结构和材料的早期应用。同时，日益复杂的采购流程和支付方日益严格的审查迫使製造商更加重视产品价值和长期疗效数据。在这段过渡时期，美洲市场往往是临床证据产生的风向标，影响其他地区的应用。

对环状成形术环领域的竞争格局、创新管道和伙伴关係模式进行策略概述，以推动差异化和临床应用。

二尖瓣环状成形术环环领域的竞争格局是由成熟的医疗技术公司、专业器材创新者、专业契约製造和专注于临床的新兴企业之间的相互作用所塑造的。市场领导通常利用其广泛的心血管产品组合、全球监管地位和长期建立的临床关係来赢得外科医生的青睐和医疗机构的采购。同时，小规模的专业公司和新参与企业则透过在环形态、材料科学和与微创手术的兼容性方面进行针对性创新来展开竞争，并透过有针对性的临床合作来建立利基市场地位。

为促进推广应用，提出切实可行的策略建议，包括加强证据收集、建构供应链、拓展产品系列以及加强相关人员合作。

产业领导者应采取一系列协同努力，将临床优势转化为永续的商业性优势。首先，他们应优先投资于比较性临床证据，以明确柔软性、刚性或半刚性结构在特定疾病状态或患者亚群中是否能带来更优的疗效。这些证据应旨在为外科医生的决策和与支付方的沟通提供基础。其次，他们应透过供应商多元化、检验关键零件的近岸替代方案以及实施库存策略来优化供应链的韧性，从而减轻贸易政策波动的影响，同时确保品质和合规性。

我们采用稳健的混合方法调查方法，结合临床医师的直接见解、文献综述、监管审查和相关人员检验，以确保分析的可靠性。

本执行摘要依据的研究整合了严谨的一手和二手研究，旨在确保其可靠性和相关性。一手数据包括对主要地区的心臟外科医生、介入性心臟病专家、医院采购人员和手术室经理进行的结构化访谈，以了解他们的临床偏好、采购因素和手术流程考虑。此外，我们也与临床领域意见领袖进行了顾问委员会讨论，以检验这些访谈对器材设计的影响，并确定证据产生的优先顺序。

简洁扼要的结论概述了设计创新、临床实践变革、区域趋势和供应链韧性如何共同塑造策略重点。

总而言之，二尖瓣环环状成形术环融合了器械工程、不断发展的外科手术实践和不断变化的商业性现实。涵盖柔软性、刚性和半刚性器械的设计创新不断适应成人、老年和儿童患者群体的细微临床需求，而聚酯、硅胶和钛等材料的选择则针对性能和影像相容性进行了优化。诸如在复杂心血管手术中推广综合方法以及在微创手术中逐步应用等手术趋势，正在重塑产品要求和临床证据预期。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依器械类型分類的医用环状成形术环市场

  • 柔软的
    • 二尖瓣
    • 单尖瓣
  • 刚性
    • 圆
    • 马鞍形状
  • 半刚性
    • 完整环
    • 开环

9. 依手术类型分類的医用二尖瓣环状成形术环市场

  • 复杂心血管手术
    • 主动脉瓣置换术
    • 冠状动脉绕道手术手术
    • 三尖瓣修復
  • 孤立性二尖瓣修復

第十章 依材料类型分類的医用二尖瓣环状成形术环市场

  • 聚酯纤维
  • 硅
  • 钛

第十一章 依病患年龄层分類的医用环状成形术环市场

  • 成人
  • 老年人
  • 儿童

第十二章 依终端使用者管道分類的医用二尖瓣环状成形术环市场

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院

第十三章 区域性医用环状成形术环市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医用二尖瓣环状成形术环市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医用二尖瓣环状成形术环市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国医用二尖瓣环状成形术环市场

第十七章：中国医用二尖瓣环状成形术环市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Affluent Medical
  • Balton SA
  • BioStable Science & Engineering Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardia Innovation AB
  • Cardiac Dimensions, Inc.
  • Colibri Heart Valve, LLC
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Endovalve Inc.
  • Genesee BioMedical
  • Getinge AB
  • Jotec GmbH
  • Labcor Laboratorios Ltda.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova plc
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Mittentia International
  • NeoChord, Inc.
  • Neovasc Inc.
  • Terumo Corporation
  • Valcare Medical
Product Code: MRR-C36616F6998B

The Medical Mitral Annuloplasty Ring Market was valued at USD 323.45 million in 2025 and is projected to grow to USD 352.32 million in 2026, with a CAGR of 8.89%, reaching USD 587.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 323.45 million
Estimated Year [2026] USD 352.32 million
Forecast Year [2032] USD 587.32 million
CAGR (%) 8.89%

A concise authoritative introduction summarizing the evolving role of mitral annuloplasty rings in contemporary cardiac repair and strategic decision-making

Mitral annuloplasty rings occupy a central role in contemporary valvular repair, shaping procedural choices, device innovation, and clinical outcomes across diverse patient populations. Over recent years, iterative improvements in ring design, material science, and implantation techniques have converged to expand therapeutic options for surgeons and cardiologists. As practitioners increasingly favor repair over replacement where clinically appropriate, attention to ring geometry, compliance, and tissue interaction has intensified, prompting manufacturers and clinical teams to re-evaluate device selection frameworks.

Consequently, stakeholders from clinical, regulatory, and commercial domains must understand the interplay between device attributes and clinical pathways. This executive summary synthesizes the most consequential trends, regulatory influences, and channel dynamics influencing annuloplasty use. It is designed for decision-makers seeking concise, actionable perspectives that bridge clinical efficacy and commercial viability. By integrating insights across device type, procedure mix, end-user settings, materials, and patient age groups, the summary supports targeted strategy development and highlights priority areas for investment, collaboration, and evidence generation.

How ongoing design innovations, material advances, procedural shifts, and regulatory expectations are redefining mitral annuloplasty ring development and adoption

The landscape of mitral annuloplasty rings is undergoing several transformative shifts that are reshaping clinical practice and industry priorities. First, device design evolution is moving beyond binary choices between rigid and flexible constructs toward hybrid solutions that aim to balance annular remodeling with physiological motion. Innovations in semi-rigid geometries and saddle-shaped rigid options are changing intraoperative decision-making by offering tailored biomechanical profiles for different pathologies.

Second, material science advances are expanding the palette of implantable substrates. Polyester remains a mainstay for its suturability and tissue integration, while silicone elements and titanium cores are being leveraged to tune stiffness and radiopacity. As a result, device developers are pursuing differentiated value propositions grounded in long-term durability and imaging compatibility. Third, shifts in procedural practice reflect a stronger emphasis on minimally invasive approaches and on integrating annuloplasty into combined cardiac procedures when clinically indicated. These procedural trends increase the demand for rings optimized for different access routes and combined operative workflows. Fourth, regulatory scrutiny and post-market evidence expectations are rising, prompting manufacturers to invest in real-world data collection and robust clinical follow-up. Collectively, these shifts create opportunities for clinical innovation while elevating the importance of cross-functional alignment between engineering, clinical affairs, and commercialization teams.

Analysis of how the 2025 tariff changes in the United States prompted supply chain resilience, sourcing shifts, and commercial adaptations for device manufacturers

Tariff policy changes in the United States during 2025 introduced nuanced headwinds and strategic recalibrations across medical device supply chains that interact with mitral annuloplasty ring availability and pricing dynamics. In practice, heightened import duties on select components and raw materials elevated landed costs, prompting manufacturers to reassess sourcing strategies and inventory policies. In response, firms accelerated nearshoring and diversified supplier networks to mitigate exposure while preserving device quality and compliance with regulatory requirements.

Moreover, these tariff-driven cost pressures influenced commercial tactics, with several companies prioritizing higher-value SKUs, bundling services, and reinforcing clinical value messaging to protect adoption pathways. Hospitals and ambulatory surgical centers faced incremental procurement complexity, which in turn influenced selection algorithms favoring devices with demonstrable procedural efficiency or long-term durability that justify their total procedural cost. Importantly, the tariff environment also catalyzed stronger collaboration between industry and health systems to identify cost-neutral pathways for maintaining patient access, such as optimizing inventory turns and leveraging consignment models. Taken together, policy shifts in 2025 triggered supply chain resilience measures and commercial adaptations that are likely to have sustained influence on sourcing, pricing discipline, and go-to-market prioritization across the sector.

Detailed segmentation-driven insights explaining how device design, procedure context, end-user setting, materials, and patient age influence clinical and commercial strategy

A nuanced segmentation framework reveals distinct clinical and commercial implications across device type, procedure type, end-user channel, material choice, and patient age group. Based on device type, the market is characterized by flexible rings that include bicuspid and monocusp designs, rigid rings that present circular and saddle-shaped geometries, and semi-rigid rings that are available as complete or open designs; each category addresses different mitral pathologies and surgical philosophies and therefore requires targeted evidence packages and surgeon education programs.

Based on procedure type, utilization divides between combined cardiac procedures and isolated mitral valve repair; within combined cardiac procedures, the clinical mix includes aortic valve replacement, coronary artery bypass grafting, and tricuspid valve repair, necessitating devices that integrate cleanly into multi-procedure operative workflows. Based on end user channel, adoption occurs in ambulatory surgical centers and hospitals, and hospitals further split into private and public institutions, where procurement cycles, reimbursement dynamics, and case complexity vary considerably. Based on material type, devices employ polyester, silicone, and titanium to balance suturability, flexibility, and radiopacity, which has implications for manufacturing processes and long-term clinical monitoring. Finally, based on patient age group, clinical considerations differ across adult, geriatric, and pediatric populations, shaping design priorities such as growth accommodation in younger patients and enhanced durability for older cohorts. Together, these segmentation lenses highlight where clinical needs, commercial models, and regulatory strategies must align to achieve differentiated market positioning.

Comparative regional insights highlighting how clinical adoption, regulatory frameworks, and payer dynamics differ across the Americas, EMEA, and Asia-Pacific

Regional dynamics continue to shape clinical practice patterns, regulatory demands, and commercialization approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong procedural volumes, high proceduralization of mitral repair, and an established network of academic centers drive early adoption of innovative ring geometries and materials, while procurement sophistication and payer scrutiny steer manufacturers to emphasize value and long-term outcomes data. Transitionally, the Americas market often acts as a beacon for clinical evidence generation that informs adoption elsewhere.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways requires nimble market entry strategies and localized evidence generation. Countries with centralized health systems demand health economic modeling and robust outcome data, whereas regions with private hospital networks may prioritize differentiated surgical efficiency. Meanwhile, Asia-Pacific presents a combination of rapid capacity expansion in tertiary centers, an increasing focus on minimally invasive pathways, and evolving reimbursement constructs that can favor scaled production and cost-effective device variants. Cross-regionally, firms are prioritizing adaptable clinical value stories and region-specific regulatory roadmaps to accelerate adoption across these diverse geographies.

A strategic overview of competitive forces, innovation pathways, and partnership models driving differentiation and clinical uptake in the annuloplasty ring sector

Competitive dynamics in the mitral annuloplasty ring arena are shaped by an interplay of established medtech firms, focused device innovators, specialized contract manufacturers, and clinical-focused start-ups. Market leaders typically leverage broad cardiovascular portfolios, global regulatory footprints, and long-standing clinical relationships to drive surgeon preference and institutional procurement. At the same time, smaller specialist companies and newer entrants often compete through targeted innovation in ring geometry, material science, and minimally invasive compatibility, carving niche positions through focused clinical collaborations.

Strategic partnerships between device designers and clinical centers remain a critical pathway for de-risking early-stage innovation and accelerating evidence generation. Manufacturers are increasingly investing in post-market clinical registries and real-world evidence initiatives to demonstrate comparative performance in diverse patient subgroups. Furthermore, the competitive landscape is influenced by manufacturing scale and supply chain control: organizations that can optimize component sourcing, streamline sterilization logistics, and maintain regulatory compliance without compromising product integrity achieve faster time-to-adoption in key centers. Collectively, these dynamics underscore the need for balanced portfolios that combine flagship products with niche offerings and an emphasis on clinician training and outcomes data to sustain market relevance.

Actionable strategic recommendations for leaders to strengthen evidence, supply chains, product portfolios, and stakeholder partnerships to accelerate adoption

Industry leaders should pursue a coordinated set of actions to convert clinical strength into sustainable commercial advantage. First, prioritize investment in comparative clinical evidence that clarifies when flexible, rigid, or semi-rigid constructs deliver superior outcomes for specific pathologies and patient subgroups; this evidence should be designed to inform surgeon decision-making and payer conversations alike. Second, optimize supply chain resilience by diversifying suppliers, validating nearshore alternatives for critical components, and implementing inventory strategies that reduce the impact of trade policy volatility while preserving quality and compliance.

Third, align product portfolios with end-user workflows by ensuring devices are optimized for hospitals and ambulatory surgical centers, and by developing tailored value propositions for private and public hospital settings. Fourth, emphasize modular commercial models that allow for procedural bundles, training services, and outcome-based contracting where appropriate, thereby linking device selection to demonstrable clinical and operational benefits. Fifth, accelerate material and design R&D focused on imaging compatibility, minimally invasive deployment, and long-term tissue integration, particularly for geriatric and pediatric use cases where clinical demands diverge. Finally, cultivate collaborative relationships with heart teams and key opinion leaders to support guideline inclusion and to drive educational programs that translate device advantages into standardized clinical practice. Together, these steps will help organizations translate technical innovation into durable market advantage.

A robust mixed-methods research approach combining primary clinician insights, literature synthesis, regulatory review, and stakeholder validation to ensure reliable analysis

The research underpinning this executive summary integrates rigorous primary and secondary inquiry designed to ensure robustness and relevance. Primary inputs include structured interviews with cardiac surgeons, interventional cardiologists, hospital procurement leaders, and operating room managers collected across major geographies to capture clinical preferences, procurement drivers, and procedural workflow considerations. These interviews were complemented by advisory board consultations with clinical thought leaders to validate device design implications and to prioritize evidence-generation needs.

Secondary inputs comprise a systematic review of peer-reviewed literature, clinical guidelines, regulatory filings, and public health agency communications to triangulate clinical outcomes, material performance, and safety profiles. Regulatory pathway analyses were assembled from public agency guidance and published conformity assessments, while supply chain and tariff implications were informed by trade policy notices and industry sourcing disclosures. Finally, all qualitative insights were cross-validated through scenario testing with commercial and clinical stakeholders to ensure practical applicability and to identify priority areas for follow-up research. This mixed-methods approach ensures that the analysis remains both clinically grounded and commercially actionable.

A concise conclusion synthesizing how design innovation, clinical practice shifts, regional dynamics, and supply chain resilience collectively shape strategic priorities

In summary, mitral annuloplasty rings stand at the intersection of device engineering, evolving surgical practice, and shifting commercial realities. Design innovation-spanning flexible, rigid, and semi-rigid constructs-continues to align with nuanced clinical needs across adult, geriatric, and pediatric cohorts, while material choices like polyester, silicone, and titanium are being optimized for performance and imaging compatibility. Procedural trends that favor integrated approaches in combined cardiac operations and incremental adoption in minimally invasive settings are reshaping product requirements and clinical evidence expectations.

At the same time, regional heterogeneity in regulatory scrutiny, payer dynamics, and hospital procurement practices necessitates tailored market entry and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Recent tariff developments have underscored the importance of supply chain agility and commercial adaptability. For stakeholders, the path forward is clear: invest in targeted evidence generation, reinforce resilient sourcing, and align product design with real-world clinical workflows to convert clinical promise into durable clinical and commercial impact. This integrated approach will help the sector deliver improved patient outcomes while navigating the complex dynamics of modern healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Mitral Annuloplasty Ring Market, by Device Type

  • 8.1. Flexible
    • 8.1.1. Bicuspid
    • 8.1.2. Monocusp
  • 8.2. Rigid
    • 8.2.1. Circular
    • 8.2.2. Saddle Shaped
  • 8.3. Semi Rigid
    • 8.3.1. Complete Ring
    • 8.3.2. Open Ring

9. Medical Mitral Annuloplasty Ring Market, by Procedure Type

  • 9.1. Combined Cardiac Procedures
    • 9.1.1. Aortic Valve Replacement
    • 9.1.2. Coronary Artery Bypass Grafting
    • 9.1.3. Tricuspid Valve Repair
  • 9.2. Isolated Mitral Valve Repair

10. Medical Mitral Annuloplasty Ring Market, by Material Type

  • 10.1. Polyester
  • 10.2. Silicone
  • 10.3. Titanium

11. Medical Mitral Annuloplasty Ring Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Medical Mitral Annuloplasty Ring Market, by End User Channel

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals

13. Medical Mitral Annuloplasty Ring Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Mitral Annuloplasty Ring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Mitral Annuloplasty Ring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Mitral Annuloplasty Ring Market

17. China Medical Mitral Annuloplasty Ring Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Affluent Medical
  • 18.7. Balton S.A.
  • 18.8. BioStable Science & Engineering Ltd.
  • 18.9. Boston Scientific Corporation
  • 18.10. Braile Biomedica
  • 18.11. Cardia Innovation AB
  • 18.12. Cardiac Dimensions, Inc.
  • 18.13. Colibri Heart Valve, LLC
  • 18.14. CryoLife, Inc.
  • 18.15. Edwards Lifesciences Corporation
  • 18.16. Endovalve Inc.
  • 18.17. Genesee BioMedical
  • 18.18. Getinge AB
  • 18.19. Jotec GmbH
  • 18.20. Labcor Laboratorios Ltda.
  • 18.21. Lepu Medical Technology Co., Ltd.
  • 18.22. LivaNova plc
  • 18.23. Medtronic plc
  • 18.24. Micro Interventional Devices, Inc.
  • 18.25. Mittentia International
  • 18.26. NeoChord, Inc.
  • 18.27. Neovasc Inc.
  • 18.28. Terumo Corporation
  • 18.29. Valcare Medical

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)